期刊文献+

人D-二聚体分离纯化及鉴定

Isolation,purification and identification of human D-dimer
下载PDF
导出
摘要 目的分离纯度较高和人D-二聚体(D-dimer),为制备抗人D-二聚体单克隆抗体提供可靠抗原。方法以凝血酶、凝血因子等处理人纤维蛋白原,得到交联纤维蛋白,经纤溶酶消化,得到交联纤维蛋白降解产物(FDP);对FDP作Sephacryl S-300凝胶过滤层析和聚焦层析,分离纯化得到D-dimer。采用免疫比浊法测定D-dimer含量、染料结合法测定纯化蛋白含量,以SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)观察D-dimer的纯化情况,WestonBlot法确认D-dimer的存在。结果制备得到的FDP SDS-PAGE图谱显示有多条蛋白条带,1条分子量为180~250kD蛋白条带在Western Blot图谱中显示可以被D-dimer单克隆抗体特异性地识别。FDP经Sephacry S-300凝胶层析和聚焦层析后得到纯度较高的D-dimer(n=3):总蛋白含量比为(77.82±7.98)%,蛋白回收率(25.27±6.35)%;SDS-PAGE图谱显示:经过两步层析得到的终产物为分子量180~250 kD的蛋白;Western Blot证实:经过Sephacryl S-300凝胶层析和聚焦层析处理,最终得到分子量为180~250 kD的终产物可被D-dimer单克隆抗体特异性识别。结论采用Sephacryl S-300凝胶层析和聚焦层析能够分离纯化获得较高纯度的D-dimer,可作为制备D-dimer单克隆抗体的抗原。 Objective To prepare isolated and purified D-dimer,which would be the antigen to prepare the mono- clonal antibody (McAb) in the future research. Methods Turned human fibrinogen into cross-linked fibrin via thrombin and Factor III. Then used plasmin to digest cross-linked fibrin into fibrin degradation products (FDP). A 2 steps flow com- prising of Sephaeryl S -300 gel filtration chromatography and focusing chromatography were used to isolate and purifie D-di- mer from FDP. The eontent of D-dimer was determined by Turbidimetrie ImmunoAssay. Ultraviolet speetroseopy was used to determine the protein content of products. The purity of products was detected by sodium dodecyl sulphate-polyaerylamide gel electrophoresis (SDS-PAGE). Western Blot was used to identify D-dimer. Results The FDP contained several kinds of protein,which were displayed in SDS-PAGE image. The western blot displayed that the monoclonal antibody against D-di- mer could specifically recognize the protein which molecular weight was between 180 kD and 250 kD in the FDP. After Sephacryl S -300 gel filtration chromatography and focusing chromatography,we got the final product, which percentage be- tween D-dimer and protein was (77. 82 ± 7. 98 ) %, and it was concentrated in (25.27 ± 6. 35 ) % yield from FDP. And the main composition of this product was the protein which molecular weight was between 180 kD and 250 kD showed in the SDS-PAGE image. The protein mentioned above which molecular weight was between 180 kD and 250 kD could be specific- ally recognized by the monoclonal antibody against D-dimer in Western Blot. Conclusion The two step-flows could well separate and purified D-dimer from FDP.
出处 《中国输血杂志》 CAS CSCD 北大核心 2013年第6期521-524,共4页 Chinese Journal of Blood Transfusion
基金 卫生部卫生公益性行业科研专项(201002005)
关键词 D-二聚体 人交联纤维蛋白 降解物 凝胶层析 聚焦层析 分离纯化 鉴定 D-dimer human cross-linked fibrin degradation products filtration chromatography focusing chromatog- raphy isolation purification identification
  • 相关文献

参考文献19

  • 1Dempfle CE, Zips S, Ergul H, et 81. Fibrin assay comparative trial study group. The Fibrin Assay Comparison Trial (FACT) : evalua- tion of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost ,2001, 85(4) :671 -678.
  • 2Francis CW, Marder V J, Martin S. Plasmic degradation of cross linked fibrin. I . Structural analysis of the particulate clot and i- dentification of new macromolecular soluble complexes. Blood, 1980,56(3) :456-464.
  • 3赵劲松,邵敏,王锦权.全身炎症反应综合征患者血浆中D—二聚体变化的意义[J].安徽医学,2004,25(3):187-188. 被引量:6
  • 4王振义,李家增,阮长耿.纤维蛋白溶解系统的实验室检查//王振义,李家增,阮长耿.血栓与止血基础理论与临床,3版,上海:上海科学技术出版社,2004:924-924.
  • 5Kroneman H, Nieuwenhuizen W, Kearon C, et al . Sensitivity and specificity of a rapid whole blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Inner Med, 1998,129 ( 12 ) : 1006- 1011.
  • 6Sie P. The value of laboratory tests in the diagnosis of venous thromboemboli sin. Hematological, 1995,80 ( 2 Suppl ) : 91 -111.
  • 7Antovie JP, Hammaarstrom KH, Forslund G, et al. Comparison of five point-of-care D-dimer assays with the standard laboratory method. Infl J Lab Heamato1,2012,34(05 ) :495-501.
  • 8Debonairness P, de Wet C, McGhee A. Compute to pographic pul- monary angiography and pulmonary embolism : predictive value of a D-dimer assay. BMC Res Notes,2012,5(104) :1-5.
  • 9Lucassen WAM, Douma RA, Tloo DB, et al. Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test : a scenario analysis . BMC Family Practice,2010,11 (64) :1-5.
  • 10Marshak DR,Kadonaga JT,Burgess RR.蛋白质纯化与鉴定实验指南,北京;科学出版社.2002:249-259.

二级参考文献45

  • 1林方昭,肖小璞,黄淑,周昌华,肖玲,周宇,赵青蓉,李湘.人凝血因子X单克隆抗体的研制及鉴定[J].四川大学学报(自然科学版),2002,39(S1):160-165. 被引量:2
  • 2王海龄,李和,于劼,肖小璞,钟峻.抗人血浆蛋白C单克隆抗体研制的初步报告[J].中国输血杂志,1995,8(1):2-5. 被引量:1
  • 3徐世洲,赵青蓉,林方昭,肖玲,肖小璞.从Cohn氏法组分Ⅲ沉淀纯化人凝血因子Ⅶ[J].中国输血杂志,2006,19(5):352-355. 被引量:1
  • 4陈实平 朱立平.杂交瘤技术与单克隆抗体制备[A].见巴德年主编.当代免疫学技术与应用 第1版[C].北京:北京医科大学·中国协和医科大学联合出版社,1998.357~358.
  • 5司徒镇强,吴军正.杂交瘤技术.见:司徒镇强,吴军正,主编.细胞培养[M].第一版.西安:世界图书出版公司,1996,232—242.
  • 6Saito H, Ratnoff OD. Partial purification of plasma thromboplastin antecedent ( factor Ⅺ) and its activation[ J]. J Clin Invest, 1973, 52 ( 4 ) : 850-856
  • 7Bouma, B, N, Griffin J, H. Human blood coagulation factor Ⅺ. Purification,properties,and mechanism of activation by activated factor Ⅻ[ J]. J Biol Chem,1977 ,252(18) :6432-6437
  • 8Saito H, Goldsmith GH Jr. Plasma thromboplastin antecedent ( PTA, factor Ⅺ) : a specific and sensitive radioimmunoassay [ J ]. Blood, 1977,50 ( 3 ) :377-385
  • 9Heimark RL, Davie EW. Bovine and human plasma prekallikrein [J]. Methods Enzymol,1981,80( Pt C) :157-172
  • 10Bumouf-Radosevich M, Bumouf T. A therapeutic, highly purified factor Ⅺ concentrate from human plasma [ J ]. Transfusion, 1992, 32(9) :861-867

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部